Drugs / Probiotic Formula Capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04223479 | Jan 2020 → Mar 2022 | ulcerative colitis | University of Jordan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Probiotic Formula Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04223479 ↗ |
| Route | Oral | “receive oral viable capsules of probiotic” NCT04223479 ↗ |